Related Experiment Video
Updated: Apr 25, 2026

A Novel High-Throughput Ex Vivo Ovine Skin Wound Model for Testing Emerging Antibiotics
Published on: September 16, 2022
Current and emerging drugs for acute bacterial skin and skin structure infections: an update
Ramya Kollipara1, Christopher Downing, Michael Lee
1Center for Clinical Studies , 1401 Binz Ave, Suite 200, Houston, TX 77004 , USA +1 713 528 8818 ; +1 713 528 8848 ; rkollipara@ccstexas.com.
Introduction:
Antibiotic resistance, the emergence of multidrug-resistant bacteria and the exponential rise of methicillin-resistant Staphylococcus aureus (MRSA) acute bacterial skin and skin structure infections (ABSSSI) pose a great threat to the public health. In order to combat these threats, development of new antibiotics is vital and measures to decrease antibiotic resistance should be prioritized.
Areas Covered:
This manuscript provides an overview of the current FDA-approved antibiotics and the antibiotics in development for MRSA ABSSSI.
Expert Opinion:
A great need exists currently for novel antibiotics to combat multidrug-resistant MRSA. As clinicians, it is imperative to implement proper management in order to reduce antibiotic resistance.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
08:11Investigation of a Blue Light LED Device to Suppress Wound Pathogens Using a Collagen-Based Synthetic Skin Model
Published on: February 24, 2026
Related Concept Videos
Staphylococcal Skin Infections
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance
Acne Infection
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Hand hygiene
Hand washing...